Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Racotumomab

😃Good
Catalog No. T77443Cas No. 946832-34-4

Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is a mouse γ-type anti-recombinant antibody that specifically induces an antibody response against Neu-glycolyl GM3 ganglioside (NeuGcGM3), overexpressed in various solid tumors. Racotumomab reacts with gangliosides containing Neu-Glycolyl (NeuGc), thioglycosides, and other tumor-expressed antigens, demonstrating anti-cancer activity, and is used in lung cancer research.

Racotumomab

Racotumomab

😃Good
Catalog No. T77443Cas No. 946832-34-4
Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is a mouse γ-type anti-recombinant antibody that specifically induces an antibody response against Neu-glycolyl GM3 ganglioside (NeuGcGM3), overexpressed in various solid tumors. Racotumomab reacts with gangliosides containing Neu-Glycolyl (NeuGc), thioglycosides, and other tumor-expressed antigens, demonstrating anti-cancer activity, and is used in lung cancer research.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$163-In Stock
5 mg$496-In Stock
10 mg$795-In Stock
25 mg$1,180-In Stock
50 mg$1,580-In Stock
100 mg$2,160-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:> 95%
Contact us for more batch information

Product Introduction

Bioactivity
Description
Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is a mouse γ-type anti-recombinant antibody that specifically induces an antibody response against Neu-glycolyl GM3 ganglioside (NeuGcGM3), overexpressed in various solid tumors. Racotumomab reacts with gangliosides containing Neu-Glycolyl (NeuGc), thioglycosides, and other tumor-expressed antigens, demonstrating anti-cancer activity, and is used in lung cancer research.
In vitro
Inducing a specific humoral and cellular immune response against the NeuGcGM3 ganglioside present in tumor cells, racotumomab stimulates cell death[4].
In vivo
In F3II cell (s.c.) mammary tumor mice models, racotumomab (50 μg/dose, i.p.) together with Keyhole limpet hemocyanin (KLH) inhibits tumor growth[2].
Against lung nodules in 3LL cell (s.c.) mice xenograft, racotumomab (50 μg/dose, s.c.) together with Pemetrexed (100 mg/kg) is highly effective[3].
However, in 3LL cell (s.c.) mice xenograft, racotumomab (50-200 μg/dose, s.c.) shows no significant antitumor effect[3].
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetGM3
Chemical Properties
Molecular Weight146.6 kDa
Cas No.946832-34-4
Antibody Information
IsotypeHuman IgG1 kappa
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Racotumomab | purchase Racotumomab | Racotumomab cost | order Racotumomab | Racotumomab in vivo | Racotumomab in vitro | Racotumomab molecular weight